نتائج البحث - "Weber, Jeffrey"

1

دورية أكاديمية

Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.

المؤلفون: Moser, Justin C., Bhatia, Shailender, Amin, Asim, Pavlick, Anna C., Betts, Keith A., Du, Ella Xiaoyan, Poretta, Tayla, Shelley, Karishma, Srinivasan, Swetha, Sakkal, Leon Alan, Palaia, Jennell, Lobo, Maurice, Pe Benito, Melanie, Linton, Joshua A., Chen, Yan, Xu, Churong, Yin, Lei, Sundar, Manasvi, Weber, Jeffrey

المصدر: Cancer Immunology, Immunotherapy; Jul2024, Vol. 73 Issue 7, p1-12, 12p

مصطلحات موضوعية: NIVOLUMAB, TREATMENT effectiveness, PROPORTIONAL hazards models, MELANOMA, OVERALL survival

النص الكامل

2

دورية أكاديمية

Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptide.

المصدر: Nature Communications; 5/22/2023, Vol. 14 Issue 1, p1-15, 15p

مصطلحات موضوعية: CELLULAR recognition, PEPTIDES, T cell receptors, ALLELES, HIV, T cells, DISEASE susceptibility, ANTIGEN presentation

النص الكامل

3

دورية أكاديمية

Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.

المؤلفون: Weber, Jeffrey S.¹ (AUTHOR) jeffrey.weber@nyulangone.org, Poretta, Tayla² (AUTHOR), Stwalley, Brian D.² (AUTHOR), Sakkal, Leon A.² (AUTHOR), Du, Ella X.³ (AUTHOR), Wang, Travis³ (AUTHOR), Chen, Yan³ (AUTHOR), Wang, Yan³ (AUTHOR), Betts, Keith A.³ (AUTHOR), Shoushtari, Alexander N.^4,5 (AUTHOR)

المصدر: Cancer Immunology, Immunotherapy. Apr2023, Vol. 72 Issue 4, p945-954. 10p.

مصطلحات موضوعية: *OVERALL survival, *NIVOLUMAB, *PLACEBOS, *MELANOMA

النص الكامل

4

دورية أكاديمية

Nanoparticle-based modulation of CD4⁺ T cell effector and helper functions enhances adoptive immunotherapy.

المؤلفون: Isser, Ariel, Silver, Aliyah B., Pruitt, Hawley C., Mass, Michal, Elias, Emma H., Aihara, Gohta, Kang, Si-Sim, Bachmann, Niklas, Chen, Ying-Yu, Leonard, Elissa K., Bieler, Joan G., Chaisawangwong, Worarat, Choy, Joseph, Shannon, Sydney R., Gerecht, Sharon, Weber, Jeffrey S., Spangler, Jamie B., Schneck, Jonathan P.

المصدر: Nature Communications; 10/14/2022, Vol. 13, p1-19, 19p

مصطلحات موضوعية: CYTOTOXIC T cells, T helper cells, IMMUNE response, T cells, HLA histocompatibility antigens, ANTIGEN presenting cells, LYSIS, ARTIFICIAL cells

النص الكامل

5

دورية أكاديمية

Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era?

المؤلفون: Berger, Assaf, Bernstein, Kenneth, Alzate, Juan Diego, Mullen, Reed, Silverman, Joshua S., Sulman, Erik P., Donahue, Bernadine R., Pavlick, Anna C., Gurewitz, Jason, Mureb, Monica, Mehnert, Janice, Madden, Kathleen, Palermo, Amy, Weber, Jeffrey S., Golfinos, John G., Kondziolka, Douglas

المصدر: Journal of Neuro-Oncology; Jul2022, Vol. 158 Issue 3, p471-480, 10p

6

دورية أكاديمية

Simplified, interpretable graph convolutional neural networks for small molecule activity prediction.

المؤلفون: Weber, Jeffrey K.¹ (AUTHOR), Morrone, Joseph A.¹ (AUTHOR), Bagchi, Sugato¹ (AUTHOR), Pabon, Jan D. Estrada¹ (AUTHOR), Kang, Seung-gu¹ (AUTHOR), Zhang, Leili¹ (AUTHOR), Cornell, Wendy D.¹ (AUTHOR) cornell@us.ibm.com

المصدر: Journal of Computer-Aided Molecular Design. May2022, Vol. 36 Issue 5, p391-404. 14p.

مصطلحات موضوعية: *CONVOLUTIONAL neural networks, *SMALL molecules, *PHARMACEUTICAL chemistry

7

دورية أكاديمية

Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition.

المؤلفون: Chat, Vylyny, Ferguson, Robert, Simpson, Danny, Kazlow, Esther, Lax, Rebecca, Moran, Una, Pavlick, Anna, Frederick, Dennie, Boland, Genevieve, Sullivan, Ryan, Ribas, Antoni, Flaherty, Keith, Osman, Iman, Weber, Jeffrey, Kirchhoff, Tomas

المصدر: Cancer Immunology, Immunotherapy; Jun2019, Vol. 68 Issue 6, p897-905, 9p

مصطلحات موضوعية: TYPE 1 diabetes, MELANOMA, BIOMARKERS, AUTOIMMUNE diseases, THERAPEUTICS

النص الكامل

8

دورية أكاديمية

Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors.

المؤلفون: Wang, Shiyang, Liechty, Benjamin, Patel, Seema, Weber, Jeffrey S., Hollmann, Travis J., Snuderl, Matija, Karajannis, Matthias A.

المصدر: Journal of Neuro-Oncology; May2018, Vol. 138 Issue 1, p183-190, 8p

9

دورية أكاديمية

The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy.

المؤلفون: Briere, David, Sudhakar, Niranjan, Woods, David M., Hallin, Jill, Engstrom, Lars D., Aranda, Ruth, Chiang, Harrah, Sodré, Andressa L., Olson, Peter, Weber, Jeffrey S., Christensen, James G.

المصدر: Cancer Immunology, Immunotherapy; Mar2018, Vol. 67 Issue 3, p381-392, 12p

مصطلحات موضوعية: CANCER treatment, NON-small-cell lung carcinoma, HISTONE deacetylase inhibitors, TUMOR antigens, IMMUNOSUPPRESSION, HLA histocompatibility antigens

النص الكامل

10

دورية أكاديمية

Correction to: Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.

المؤلفون: Weber, Jeffrey S.¹ (AUTHOR) jeffrey.weber@nyulangone.org, Poretta, Tayla² (AUTHOR), Stwalley, Brian D.² (AUTHOR), Sakkal, Leon A.² (AUTHOR), Du, Ella X.³ (AUTHOR), Wang, Travis³ (AUTHOR), Chen, Yan³ (AUTHOR), Wang, Yan³ (AUTHOR), Betts, Keith A.³ (AUTHOR), Shoushtari, Alexander N.^4,5 (AUTHOR)

المصدر: Cancer Immunology, Immunotherapy. Apr2023, Vol. 72 Issue 4, p955-955. 1p.

مصطلحات موضوعية: *OVERALL survival, *NIVOLUMAB, *MELANOMA, *PLACEBOS

النص الكامل

تنقيح النتائج